anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
OKYO Pharma · conference-presentation

OKYO Pharma | Results Presentation Deck | 25 slides

25 pages · 3 arc beats · 2 loops

Conference-Presentation Download JSON
Unlock

OKYO Pharma | Results Presentation Deck | 25 slides

OKYO Pharma · 2023-06
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

3
coverage by narrative range · generated from this deck JSON
Narrative range 5 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 2 slides 100% 2/2 slides 100% 2/2 slides · 13 hits
— 0/2 slides
100% 2/2 slides 50% 1/2 slides 100% 2/2 slides
— 0/2 slides
Agitate 2 slides 100% 2/2 slides 100% 2/2 slides · 8 hits
— 0/2 slides
— 0/2 slides
— 0/2 slides
100% 2/2 slides
— 0/2 slides
Solution 1 slides 100% 1/1 slides 100% 1/1 slides · 7 hits
— 0/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides
— 0/1 slides

Slide inventory

25
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detail
02
other
Open slide detail
03
Features a molecular structure illustration.front_matter
Open slide detail
04
The chart uses a horizontal bar format to represent clinical trial progression stages.plan_implementation
Open slide detail
05
plan_implementation
Open slide detail
06
frame_problem
Open slide detailBeat · Problem
07
The slide uses a table to frame the problem by contrasting existing market solutions with their clinical and commercial shortcomings.diagnose_problem
Open slide detailBeat · Problem
08
DED stands for Dry Eye Disease.size_opportunity
Open slide detailLoop · Cost Of Inaction
09
The slide features a molecular structure illustration of the lipid-conjugated peptide.establish_context
Open slide detail
10
The slide uses a numbered process diagram to illustrate the biological mechanism of the drug candidate OK-101.present_solution
Open slide detail
11
The slide depicts a molecular mechanism of action (MOA) for a pharmaceutical compound.present_solution
Open slide detail
12
The slide uses two dose-response curves to illustrate the efficacy of membrane anchoring.analyze_data
Open slide detailLoop · Before After
13
The chart shows that OK-101 (0.04%) reduces corneal permeability to levels comparable to Cyclosporine (0.1%) and significantly better than the phosphate buffer analyze_data
Open slide detailLoop · Before After
14
Data source: Patil et al. (2019).analyze_data
Open slide detailLoop · Before After
15
diagnose_problem
Open slide detailBeat · Agitate
16
The slide uses a diagram to explain the surgical model and a bar chart to show the comparative efficacy results over 14 days.illustrate_case
Open slide detailBeat · Agitate
17
The slide uses a circular diagram to represent the 'Dry Eye Cycle' and overlays the drug's mechanism of action as an intervention.present_solution
Open slide detailBeat · Solution
18
transition
Open slide detail
19
plan_implementation
Open slide detail
20
The slide uses a process-flow diagram to illustrate the 3-arm study structure.present_framework
Open slide detail
21
PTA refers to Patent Term Adjustment.analyze_data
Open slide detail
22
Includes both M&A transaction details and public market capitalization data for peer companies.compare_peers
Open slide detail
23
The slide uses a split-column layout to distinguish between Management and Board members, accompanied by logos of relevant past/current affiliations.introduce_nominees
Open slide detail
24
summarize
Open slide detail
25
Closing slide with corporate contact details.appendix
Open slide detail